Merriman Capital Acted as Co-Manager in Avanir Pharmaceuticals, Inc.'s Follow-on Offering

Merriman Capital, Inc., a wholly owned subsidiary of Merriman Holdings, Inc. (Nasdaq:

), acted as co-manager in Avanir Pharmaceuticals, Inc.'s (Nasdaq:

) $88 million follow-on offering of common stock at $4.40 per share. The transaction closed yesterday.